
|Articles|June 15, 2003
Verteporfin praised for sight-saving potential
Fort Lauderdale, FL-Novartis Ophthalmics and QLT Inc. have received the 2003 Helen Keller Prize for Innovation in Eye Care for their development of verteporfin for injection (Visudyne) therapy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















